Skip to main content
. Author manuscript; available in PMC: 2010 May 20.
Published in final edited form as: Bioconjug Chem. 2009 May 20;20(5):937–943. doi: 10.1021/bc800520d

Figure 3.

Figure 3

A) Representative MR images of the aorta of apoE-KO mice pre- and 24 hours post-injection with 18A-Gd (left panels) and 37pA-Gd (right panels). B) Summary of the mean normalized enhancement ratio (% NER) at 24, 48, 72 and 96 hours in the aorta walls of apoE-KO mice injected with 18A-Gd or 37pA-Gd. Error bars are one standard deviation.

HHS Vulnerability Disclosure